3 min read

Earnings Reports — September 04, 2026 — After Hours — Last 12 Hours (Pacific Time)

Virco crushed earnings with a $0.50 EPS beat, while Pro-Dex also delivered strong results—but Vivendi stumbled 4% on restructuring headwinds in tonight's light but quality earnings window with a 75% beat rate.

Executive Summary

Tonight's after-hours earnings window was light on volume but strong on quality — three of four reporting companies beat EPS estimates, yielding a 75% beat rate with no outright double misses. The standout surprise came from Virco, which crushed estimates by $0.50, while Vivendi was the lone sore spot, with shares sliding 4% on restructuring headwinds. Small-cap industrials and niche tech dominated the tape, with no major large-cap names in the mix.


Earnings Performance Breakdown

Company Ticker EPS Result Revenue Result Classification
Virco VIRC Beat (+$0.50) Beat 🟢 Double Beat
Pro-Dex PDEX Beat (+$0.21) Beat 🟢 Double Beat
Domo DOMO Beat (+$0.05) Miss ⚪ Mixed
Vivendi VIVEF Not specified Not specified 🔴 Bearish Reaction*

*Vivendi's headline focuses on a stock reaction and restructuring costs rather than a clean EPS beat/miss comparison, so it is not classified as a standard double beat or miss. The 4% share decline and restructuring impact are noted as the key data points.

Summary Count:

  • 🟢 Double Beat: 2 (50%)
  • ⚪ Mixed: 1 (25%)
  • 🔴 Bearish/Unclear: 1 (25%)

Notable Earnings Reports

🟢 Virco (VIRC) — Double Beat

  • EPS of $0.550 vs. estimate of $0.050 — a massive $0.50 upside surprise
  • Revenue also topped estimates
  • A blowout quarter for the furniture manufacturer; the scale of the EPS beat relative to the estimate is extraordinary and warrants close attention

🟢 Pro-Dex (PDEX) — Double Beat

  • Q1 EPS of $0.87 vs. estimate of $0.66 — beat by $0.21
  • Revenue also topped estimates
  • Solid execution from this small-cap precision tools and medical device company, beating on both top and bottom lines

Domo (DOMO) — Mixed

  • Q2 EPS of $0.05 vs. estimate of $0.00 — beat by $0.05
  • Revenue fell short of estimates
  • The profitability improvement is encouraging for this cloud analytics platform, but the revenue miss signals continued top-line pressure

🔴 Vivendi (VIVEF) — Bearish Reaction

  • Shares fell 4% following first-half results
  • Results were hit by restructuring costs, weighing on adjusted earnings
  • No specific EPS beat/miss figures were provided in available context; the market's reaction reflects concern over the cost of ongoing corporate restructuring

Sector Analysis

Strength:

  • Industrials / Furniture (Virco): A massive earnings beat suggests demand conditions for commercial/educational furniture may be stronger than expected heading into fall procurement cycles.
  • Medical Devices / Precision Manufacturing (Pro-Dex): Continued execution strength in niche industrial tools and surgical device components — a quiet but consistent performer.

Weakness:

  • Media / Entertainment (Vivendi): Restructuring costs are clearly biting into profitability for the French media conglomerate, and the 4% share drop reflects investor frustration with the pace and cost of transformation.

Mixed:

  • Cloud / SaaS (Domo): The EPS flip to positive is a milestone, but missing revenue estimates keeps the growth narrative under pressure. The sector-wide theme of profitability-over-growth continues to play out here.

Biggest Movers

Company Move Driver
Vivendi (VIVEF) 🔴 -4% Restructuring costs hit first-half earnings
Virco (VIRC) No price move stated $0.50 EPS beat — largest surprise of the session
Domo (DOMO) No price move stated Mixed quarter — EPS beat, revenue miss
Pro-Dex (PDEX) No price move stated $0.21 EPS beat with revenue upside

Stock reactions beyond Vivendi's 4% decline were not specified in available reporting.


Market Implications

Tonight's results reinforce a familiar post-pandemic theme: smaller, operationally focused companies are finding ways to beat on the bottom line even when the macro environment is uncertain. Virco's outsized beat is a notable data point for anyone tracking institutional and educational spending — if procurement budgets are flowing, it's a quiet signal of underlying economic activity.

Vivendi's stumble is a reminder that media conglomerates undergoing structural transformation carry real execution risk. Restructuring costs are not a one-quarter story, and investors appear to be losing patience with the timeline. This is worth watching for anyone with European media exposure.

The Domo result is a microcosm of the broader SaaS landscape: profitability is improving, but growth is the harder problem. A company hitting EPS of $0.05 against a $0.00 estimate is technically a beat — but if revenue continues to disappoint, the sustainability of that profitability improvement will be questioned.


Vlad's Key Takeaways

  • 🟢 Virco (VIRC) — A $0.50 EPS beat on a $0.05 estimate is one of the largest relative surprises you'll see; worth investigating what drove the outperformance
  • 🟢 Pro-Dex (PDEX) — Quiet double beat from a small-cap precision manufacturer; consistent execution in a niche market
  • Domo (DOMO) — EPS turned positive, but revenue miss keeps growth concerns alive for this cloud analytics platform
  • 🔴 Vivendi (VIVEF) — 4% share drop signals market frustration with restructuring costs dragging on first-half results
  • 📊 Beat rate tonight was 75% — but the sample size is small; don't over-index on this as a broad market signal
  • 💡 Virco's beat may hint at stronger-than-expected institutional/educational spending — a potential leading indicator worth tracking
  • ⚠️ Vivendi's restructuring drag is a cautionary tale — transformation costs can linger longer than management timelines suggest
  • 🔍 Domo's revenue miss in a beat quarter — a pattern common in SaaS right now; profitability improving but growth remains elusive
  • 🏭 Small-cap industrials outperformed tonight — VIRC and PDEX both delivered clean double beats
  • 📉 No large-cap names reported tonight — broader market implications from this session are limited

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/